Keflex and cephalexin are not two different antibiotic ingredients. Keflex is the historical brand name, while cephalexin is the established generic name of the active ingredient. FDA-approved generic products may be used as appropriate under prescribing and pharmacy substitution rules, but a familiar brand label does not ensure that the original branded package is currently marketed.
This comparison focuses on ingredient identity, FDA generic equivalence and what a pharmacy may dispense—not an extended chronology of Keflex. For that background see Keflex brand history. For the current generic product family visit generic cephalexin. Neither name authorizes over-the-counter antibiotic use.
If your prescription says Keflex but the pharmacist provides cephalexin, verify the active ingredient, dosage form, strength and label directions. A switch to another antibiotic or a different cephalexin strength is a separate decision and should not be inferred from the brand-generic relationship.
Keflex is a brand name that historically identified cephalexin; cephalexin is the drug’s generic name. The names point to the same antibacterial active ingredient rather than separate antibiotic classes.
A patient can still be shown the Keflex name on an older prescription or health record while the dispensing product is labeled generic cephalexin. The pharmacy label should make the actual active ingredient, strength and instructions clear.
| Your next question | Relevant Core guide | What it covers |
|---|---|---|
| Historical brand status | Keflex history | See discontinued brand records |
| Generic category | Generic cephalexin | Review active products and strengths |
| Substitution rules | Generic substitution | Learn how pharmacy decisions work |
| Compare dosage forms | Forms hub | Distinguish capsules, tablets and liquid |
| Need current Rx access | Buying guide | Find lawful prescription fulfillment |
The active ingredient determines a medicine’s pharmacologic identity, but a pharmacy product also has a dosage form, strength, route, inactive ingredients and specific FDA application. A cephalexin capsule is not simply interchangeable with any volume of cephalexin suspension.
A drug comparison should therefore examine the active ingredient first and then verify the precise product prescribed. See forms and strengths for product-level detail.
A direct comparison is easiest when one label says Keflex and another says cephalexin but both identify the same active molecule. This is different from comparing cephalexin with cefadroxil or another cephalosporin: those medications are related by class but not identical active ingredients. A page answering “same drug?” should make that distinction explicit.
FDA evaluates generic products under approval pathways requiring appropriate pharmaceutical and, where applicable, bioequivalence evidence. Orange Book therapeutic-equivalence codes apply to qualifying pharmaceutical equivalents and specific product groups.
“Generic” does not mean the pharmacy may exchange any strength, route or dosage form at will. The exact substitution requires a relevant approved comparator and compliance with the prescription and state pharmacy rules.
FDA therapeutic equivalence concerns defined pharmaceutical equivalents under specified criteria. It does not automatically follow from a common therapeutic indication, and it should not be inferred from matching capsule colors. An actual pharmacy switch should be evaluated at the product level, not based on how the drug name appears on a search results page.
The original Keflex capsule entries appear in the discontinued section of the Orange Book. That status concerns the historic branded presentations, not a blanket withdrawal of cephalexin medicines.
Consequently, a search for Keflex may be answered through modern approved generic cephalexin options, rather than a promise to supply an old brand package. Read the Keflex product history for the regulatory distinction.
No. Different approved manufacturers can use different colors, imprint codes and packaging, while still meeting applicable requirements for a therapeutically equivalent generic. Appearance alone is not a reliable measure of drug identity.
Compare the printed product name, strength, route, imprint and pharmacy label; consult the pharmacist if a refill looks different or if a patient has an allergy to a known inactive ingredient.
A pharmacy may need to call the prescriber if the prescription is ambiguous, specifies dispensing restrictions, or the available product does not match the ordered strength or form. Switching between capsules and liquid may change administration instructions even when the active ingredient is the same.
Use the substitution decision guide for the process, not a self-conversion based on milligrams alone.
The prescribed timing, course length and individual dose depend on the infection and patient factors. A tablet bearing a certain number of milligrams is not inherently the correct replacement for multiple capsules or a given liquid volume.
Even with the same ingredient, changes to the prescribed schedule or form require professional verification. Clinical dosing information belongs in the dosing hub and the actual patient prescription.
Someone prescribed cephalexin 500 mg should not interpret the brand-generic relationship as permission to take two 250 mg units or a particular liquid volume without confirming the directions. Such calculations can interact with available strengths, dosing frequency and prescriber intent. The pharmacist can clarify precisely what was authorized.
Generic cephalexin products can be supplied under different labels or by different approved applicants. When pharmacists evaluate substitution they consider active ingredient, route, dosage form, strength, product approval and applicable equivalence status.
Public NDC records help identify packaging, but an NDC alone does not constitute FDA approval. See manufacturer and labeler distinctions.
A low pharmacy quote may be for a specific generic capsule, a cash-discount program or a different quantity than the prescription. Brand versus generic labels cannot by themselves predict the patient cost.
Verify the actual product and payment route before comparing prices, including insurance rules. The cephalexin pricing guide explains how to compare equivalent quotes.
A brand-name comparison can be meaningful clinically yet irrelevant to the patient’s payment choice when the original brand is not marketed. Ask about the dispensed generic, not whether an old Keflex sticker would command a different price. The pharmacist should distinguish ingredient identity, available product and benefit processing.
Brand-to-generic equivalence does not eliminate allergy risks, interactions, renal considerations or resistance. Cephalexin does not cover all organisms associated with every UTI or skin infection, and it is not a treatment for viral disease.
A clinician should determine whether cephalexin is appropriate in the first place; generic equivalence concerns which approved cephalexin product fulfills that decision.
Keflex and cephalexin refer to the same active ingredient, but the original branded line is a historical entity. At the pharmacy, verify a current approved generic that matches the written prescription under applicable substitution rules.
No source on this page confirms live inventory of a Keflex-branded item, and no commercial referral guarantees a pharmacy will dispense a particular manufacturer.
Yes. Keflex is a historical brand name for cephalexin, the active antibiotic ingredient.
FDA-approved therapeutically equivalent generics must meet applicable quality and bioequivalence standards. Their strength and form must match the prescription.
The original Keflex capsule products are in the FDA Orange Book discontinued section; do not assume current brand stock.
Manufacturers can use different appearance and inactive ingredients. Check the imprint and label with the pharmacist rather than using color alone.
Often an approved equivalent may be dispensed when lawful and consistent with the prescription, but substitution rules and product matching apply.
No. A dosage-form change may require revised instructions and professional verification.
Not necessarily. The active ingredient can remain cephalexin, but verify the actual product, equivalence and prescription details.
Yes. Cephalexin is a prescription antibiotic in the United States regardless of brand name.